期刊
HIV MEDICINE
卷 9, 期 10, 页码 868-874出版社
WILEY
DOI: 10.1111/j.1468-1293.2008.00639.x
关键词
antiretroviral therapy; gestational diabetes mellitus; HIV infection; pregnancy; protease inhibitor
资金
- FIPSE (Fundacion para la Investigacion y Prevencion del SIDA en Espana)
- FundacioBarcelonaSIDA2002
Objectives We undertook a prospective study to estimate the prevalence of gestational diabetes mellitus (GDM) and associated risk factors in a cohort of 669 HIV-1 infected women. Methods The O'Sullivan and glucose tolerance tests were performed during regular visits of 609 mothers. Results The median age of the cohort was 30.7 years (range 16-44), with most women having had heterosexual contact (67%). The majority were in Centers for Disease Control (CDC) category A (71%) and 53% exhibited hepatitis C co-infection. Median viral load and CD4 count at third trimester were 545 cells/mu L (range 139-1690 cells/mu L) and 1.9 log (range 1.7-5.4), respectively. Seventy-four per cent of the patients were treated with highly active antiretroviral therapy (HAART), of whom 41% received a protease inhibitor (PI). An above-average prevalence of 7% [95% confidence interval (CI) 5.2-9.5] for positive GDM diagnosis was found. Risk factors associated with GDM in univariate analysis included older age, hepatitis C co-infection, stavudine and PI exposure. However, only older age [adjusted odds ratio (AOR) 1.09, 95% CI 1-1.1] and PI exposure (AOR 2.4, 95% CI 1-5.3) remained as independent risk factors for GDM development in multivariate analysis. Conclusions In our cohort, the prevalence of GDM appears to be increased, with older age and PI exposure contributing as significant independent risk factors.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据